For Spectral shareholders it looks like all these are inevitable.  This 300K shares traded today have now manipulated the stock price to where it was a year ago.

Before Baxter deal (USD$5 mill upfront with all future terms heavily redacted), share sale ($5.1 mill), Paradigm ($4 per share value), COVID treatment (FDA and Health Canada approval) and DIMI approval.  Oh yeah and also progression with something called TIGRIS.

The stench from multiple successes taking the share price way down to year ago levels.  Chris - even better buy at $0.42?  Just normal garden variety market forces at work.